On November 9, the National Assembly discussed in plenary draft amendments to the laws on medical examination and treatment, pharmaceuticals and health insurance.
Deputy Nguyen Khanh Vu said the current law requires insured patients to pay costs outside their coverage, but does not give them the right to learn those amounts in advance.
Coverage ranges from 80% to 100%, depending on where patients receive care and the payment rate for some medicines and services. Patients therefore cannot calculate their own share.
Vu said the draft amendments still do not establish a patient's right to know these costs in advance. Voters had reported cases in which a patient was prescribed eight medicines, seven of them outside the health insurance list and therefore paid for personally.
Patients also sometimes buy medicines and medical supplies that the insurance fund is supposed to cover. In some cases, patients had to pay extra even after following the required procedures, and the Ministry of Health had to take corrective action.
Vu proposed adding a rule requiring patients to be told in advance about costs for medicines, medical equipment and technical services outside their coverage. Emergency cases would be excluded. The government would set the content and format of the notice.
He said the rule would not interfere with doctors' professional decisions, but would let patients know the cost in advance and choose a service that fits their financial situation.
Vu also said many doctors are troubled by cases in which they know a more effective medicine exists but it is not on the insurance list. Not prescribing it may lead to a less satisfactory treatment result, while the patient has to pay personally.
Under Article 21 of the health insurance law, the insurance fund pays only for medicines on the approved list. When a medicine outside the list is prescribed, the patient pays its full cost, including the amount the fund would have paid for a listed medicine. The draft amendments do not resolve this case and instead leave the government to set the coverage level.
The drafting body said patients do not lose their health insurance benefits and keep them when they choose a more expensive service themselves. However, they lose that benefit when they choose a better medicine based on a doctor's professional prescription.
Vu called this unfair to people with low incomes and those in difficult circumstances. He proposed that when a medicine outside the list is prescribed, the insurance fund should pay the listed-medicine rate and the patient should pay the difference.

Deputy Ha Anh Thu from Quang Ngai Province also called for greater attention to access to medicines prescribed by doctors. Prescriptions should be based on the patient's condition, the medicine's effectiveness and its safety.
She said a review of the health insurance medicine list should first consider newer medicines with evidence of clear benefits, such as extending life, reducing complications or lowering the risk of serious side effects. The review should also identify the patient groups most likely to benefit, assess the cost of the full course of treatment and consider the insurance fund's ability to pay.
If a prescribed medicine is covered but unavailable at a hospital, the hospital must explain the situation and find a way to ensure treatment. If a suitable substitute exists, the doctor should explain the medical grounds for choosing it.
If a patient has to buy a medicine personally and qualifies for direct reimbursement, the hospital must issue a certificate confirming the shortage and explain how to submit documents and the receipt to the social insurance agency. The agency would reimburse the patient based on the quantity, the receipt price, the payment price limit and the applicable coverage rate.
For a medicine outside the coverage, the hospital must explain why it was prescribed and how much the patient must pay. Thu said patients should receive this information before buying the medicine.
Sources: Thanh Niên


